Leslie Wyatt
Authored Items
By Leslie Wyatt
Web Exclusives
Delaying medication processing is common, especially when it comes to oral cancer therapies. Oncologists at 3 oncology clinics looked at such barriers and the potential impact on patient outcomes. Read More ›
Ruxolitinib Reduces Spleen Size and Improves Disease-Related Symptoms in Patients with Lower-Risk MF
By Leslie Wyatt
TOP - February 2016, Vol 9, No 1
Although there have been several trial-based studies on the use of ruxolitinib in patients with lower-risk myelofibrosis (MF), Keith L. Davis, MA, Senior Director of Health Economics at RTI Health Solutions and colleagues sought to conduct a study in the real-world setting. Read More ›
By Leslie Wyatt
TOP - February 2016, Vol 9, No 1
Great advances have been made in our understanding of how myeloproliferative neoplasms (MPNs)–essential thrombocythemia, polycythemia vera, myelofibrosis (MF)–result in overproduction of inflammatory markers, according to Holly L. Geyer, MD, Assistant Professor of Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Scottsdale, AZ, and colleagues. Read More ›